Bamco Inc Merck & Co., Inc. Transaction History

Bamco Inc

$36.8 Billion
Q3 2024

A detailed history of Bamco Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bamco Inc holds 52,400 shares of MRK stock, worth $5.15 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

52,400

Previous 90,000 41.78%

Holding current value

$5.15 Million

Previous $11.1 Million 46.6%

% of portfolio

0.02%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $4.18 Million - $4.85 Million	-37,600 Reduced 41.78%	52,400 $5.95 Million
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $294,424 - $343,069	2,600 Added 2.97%	90,000 $11.9 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $1.31 Million - $1.43 Million	12,100 Added 16.07%	87,400 $10.1 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $514,700 - $574,300	5,000 Added 7.11%	75,300 $8.01 Million
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $1.38 Million - $1.77 Million	15,800 Added 28.99%	70,300 $7.8 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $608,616 - $683,712	7,200 Added 15.22%	54,500 $4.69 Million
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $1.5 Million - $1.7 Million	18,000 Added 61.43%	47,300 $4.31 Million
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $2.15 Million - $2.41 Million	29,300 New	29,300 $2.4 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $680,423 - $943,098	-10,739 Closed	0 $0
Q4 2019 Feb 18, 2020	BUY	$77.58 - $87.54 $258,108 - $291,245	3,327 Added 44.89%	10,739 $977,000
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $274,420 - $299,128	3,607 Added 94.8%	7,412 $624,000
Q2 2019 Aug 15, 2019	BUY	$69.84 - $81.59 $265,741 - $310,449	3,805 New	3,805 $319,000

Others Institutions Holding MRK

# of Institutions

3,828

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $249B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.

Account